Stay updated on Switch to Dolutegravir + Rilpivirine Clinical Trial
Sign up to get notified when there's something new on the Switch to Dolutegravir + Rilpivirine Clinical Trial page.

Latest updates to the Switch to Dolutegravir + Rilpivirine Clinical Trial page
- CheckyesterdayChange DetectedIPD sharing information, study documents, and related metadata were removed from the Study Details page, reducing public access to data-sharing details and essential documentation.SummaryDifference19%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page revision has been updated from v3.6.3 to v3.6.4, indicating a new version of the page. This update appears to involve minor deployment changes without altering the study content or displayed information.SummaryDifference0.0%

- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedUpdated the page revision from v3.6.0 to v3.6.3 on the Study Details page, reflecting a newer revision tag for the entry. The modification concerns metadata about the page update and does not change the study data or descriptions.SummaryDifference0.0%

- Check43 days agoChange DetectedA Lancet publication citation by Llibre et al. describing the SWORD-1 and SWORD-2 studies was removed from the Publications section of the NCT02429791 study page. The Publications section now lists fewer associated publications.SummaryDifference0.1%

- Check51 days agoChange Detected- The page now displays a recruitment status note No longer looking for participants and adds user guidance sections How to Read a Study Record, Common Questions, and How to Join a Study. - The label 'Intervention / Treatment' was removed and replaced with 'Intervention/Treatment'; the revision note updated from v3.5.5 to v3.6.0.SummaryDifference0.2%

- Check58 days agoChange DetectedThe page’s revision tag has been updated from v3.5.4 to v3.5.5, signaling a new site/template release rather than changes to the study details.SummaryDifference0.0%

Stay in the know with updates to Switch to Dolutegravir + Rilpivirine Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Switch to Dolutegravir + Rilpivirine Clinical Trial page.